div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220412035d50e47d88c993cb1f8b6c0chtml5page1jpg target=_blank img data-url=documentresponse-rate-in-refractory-b-cell-nhl-patients-and-a-3040-partial-responsehtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: oncologyaeoncologyaewp-contentuploads201608Targeted-Therapy-on-Angiogenesispdfcomplete response rate in refractory B-cell NHL patients and a 30—40% partial response rate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsnetreader042viewer20220412035d50e47d88c993cb1f8b6c0chtml5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220412035d50e47d88c993cb1f8b6c0chtml5page2jpg target=_blank img data-url=documentresponse-rate-in-refractory-b-cell-nhl-patients-and-a-3040-partial-responsehtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: oncologyaeoncologyaewp-contentuploads201608Targeted-Therapy-on-Angiogenesispdfcomplete response rate in refractory B-cell NHL patients and a 30—40% partial response rate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader042fdocumentsnetreader042viewer20220412035d50e47d88c993cb1f8b6c0chtml5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader042fdocumentsnetreader042viewer20220412035d50e47d88c993cb1f8b6c0chtml5page3jpg target=_blank img data-url=documentresponse-rate-in-refractory-b-cell-nhl-patients-and-a-3040-partial-responsehtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3:...